Last update: Oct. 11, 2017
Minimal risk for breastfeeding and infant.
A corticosteroid with a mainly glucocorticoid action and moderate anti-inflammatory effects (ATC D07AB), slightly higher than that of prednisolone (ATC D07AA).
Indicated inhaled use in the treatment of inflammatory diseases of the respiratory system: bronchitis, asthma, rhinitis, etc.
This comment is about inhaled triamcinolone.
Since the last update we have not found published data about its excretion in breast milk.
After inhaled administration, the bioavailability is 25% (Argenti 1999) and the plasma levels reached are clinically insignificant (Zaborny 1992).
There is consensus among experts that, in general, neither systemic corticoids nor inhaled ones present a breastfeeding contraindication (National Asthma Education 2004).
Corticoids are of commonally used in pediatrics and have no side effects when they are used in isolation or in short-term treatments.
We do not have alternatives for Triamcinolone Inhaled since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Confederación Nacional de Pediatría (CONAPEME) from Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM